This page uses content from Wikipedia and is licensed under CC BY-SA.

Heptabarb

Heptabarb
Heptabarbital.svg
Clinical data
SynonymsG-475
Routes of
administration
Oral[1]
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability83%[1]
MetabolismHepatic
Elimination half-life6.1-11.2 hours[1]
ExcretionRenal[1]
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.007.371 Edit this at Wikidata
Chemical and physical data
FormulaC13H18N2O3
Molar mass250.294 g/mol g·mol−1
3D model (JSmol)
  (verify)

Heptabarb (INN; Eudan, Medapan, Medomin, Noctyn), also known as heptabarbitone (BAN) or heptabarbital, is a sedative and hypnotic drug of the barbiturate family.[2][3] It was used in Europe for the treatment of insomnia from the 1950s onwards, but has since been discontinued.[2][3]

See also

References

  1. ^ a b c d Breimer DD, de Boer AG (December 1975). "Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man". European Journal of Clinical Pharmacology. 9 (2–3): 169–78. doi:10.1007/bf00614014. PMID 9299.
  2. ^ a b C. R Ganellin; D. J Triggle; F.. Macdonald (1997). Dictionary of pharmacological agents. CRC Press. p. 1003. ISBN 978-0-412-46630-4. Retrieved 26 November 2011.
  3. ^ a b Index nominum 2000: international drug directory. Taylor & Francis US. 2000. p. 513. ISBN 978-3-88763-075-1. Retrieved 26 November 2011.